tradingkey.logo
搜尋

ICU Medical Inc

ICUI
添加自選
146.600USD
-1.330-0.90%
收盤 06/30, 16:00美東報價延遲15分鐘
3.66B總市值
78.10本益比TTM

ICU Medical Inc

146.600
-1.330-0.90%
查看詳細走勢圖
TradingKey 图表
盤中分時
1分
30分
1小時
日k
週k
月k
日k

今天

-0.90%

5天

+8.18%

1月

+8.28%

6月

+2.75%

今年開始到現在

+2.75%

1年

+10.93%

關鍵數據
147.930今開
148.318最高
171.02K成交量
78.10本益比TTM
15.30本益比動
--股利TTM
0.69%換手率
147.930昨收
143.855最低
18.98M成交額
虧損本益比靜
1.70市淨率
0.00%股息率 TTM
1.13%ROA
160.29052週最高
0.39量比
-117.69M淨利潤
24.69M總股本
1.8772每股盈餘TTM
0.78Beta
2.26%ROE
107.00052週最低
3.02%振幅
38.89%毛利率
3.66B總市值
5.99回報/風險
2.06%風險率

TradingKey ICU Medical Inc股票評分

單位: USD 更新時間: 2026-06-30

操作建議

ICU Medical Inc當前公司基本面數據相對健康,增長潛力較大。當前估值合理,在醫療設備與耗材行業排名25/204位。機構持股佔比非常高,近一月多位分析師給出公司評級為買入。最高目標價為171.71。中期看,股價處於上升通道。近一個月,市場表現較強,技術面和基本面綜合得分較高,較強的走勢獲得基本面和技術面的印證。目前股價在壓力位和支撐位之間,可以做區間波段操作。

ICU Medical Inc評分

相關信息

行業排名
25 / 204
全市場排名
86 / 4569
所屬行業
醫療設備與耗材

壓力支撐

由於公司未披露,未能獲取相關數據

多維評測

本期評分
上期評分

公司輿情

過去24小時
熱度

過冷
過熱
中性

ICU Medical Inc亮點

亮點風險
ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
業績轉盈
公司業績轉盈,最新年度盈利美元
估值高估
公司最新PE估值78.10,處於3年歷史高位
機構加倉
最新機構持股28.59M股,環比增加2.18%

分析師目標

基於 7 分析師
買入
評級
171.714
目標均價
+16.08%
漲幅空間

ICU Medical Inc新聞

即將為您帶來更多新聞,敬請期待。 。 。

財務指標

每股收益

由於公司未披露,未能獲取相關數據

營業總收入

由於公司未披露,未能獲取相關數據

ICU Medical Inc簡介

ICU Medical, Inc. develops, manufactures, and sells medical products used in infusion therapy, vascular access, and vital care applications. Its product portfolio includes ambulatory, syringe, and large volume IV pumps and safety software; dedicated and non-dedicated IV sets, needlefree IV connectors, peripheral IV catheters, and sterile IV solutions; closed system transfer devices and pharmacy compounding systems; as well as a range of respiratory, anesthesia, patient monitoring, and temperature management products. Its Infusion Therapy products include Clave needlefree products, Neutron, ClearGuard, and Tego. Its oncology products include ChemoLock Closed System Transfer Devices (CSTD) and Deltec GRIPPER non-coring needles for portal access. Its vascular access products include Safe-T Wing venipuncture and blood collection devices; Port-A-Cath implantable port, and Portex arterial blood sampling syringes. Its Tracheostomy products include Portex BLUselect PVC tracheostomy tubes.
公司代碼ICUI
公司ICU Medical Inc
CEOJain (Vivek)
網址https://www.icumed.com/

常見問題

ICU Medical Inc(ICUI)的當前股價是多少?

ICU Medical Inc(ICUI)的當前股價是 146.60。

ICU Medical Inc 的股票代碼是什麼?

ICU Medical Inc的股票代碼是ICUI。

ICU Medical Inc股票的52週最高點是多少?

ICU Medical Inc股票的52週最高點是160.29。

ICU Medical Inc股票的52週最低點是多少?

ICU Medical Inc股票的52週最低點是107.00。

ICU Medical Inc的市值是多少?

ICU Medical Inc的市值是3.62B。

現在ICU Medical Inc(ICUI)的股票是買入、持有還是賣出?

根據分析師評級,ICU Medical Inc(ICUI)的總體評級為買入,目標價格為171.71。

ICU Medical Inc(ICUI)股票的每股收益(EPS TTM)是多少

ICU Medical Inc(ICUI)股票的每股收益(EPS TTM)是0.03。